Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome (2018)

Peer-Reviewed Study · Gordon LB, Shappell H, Massaro J, D'Agostino RB Sr, Brazier J, Campbell SE, Kleinman ME, Kieran MW · April 24, 2018

Gordon LB et al., 2018-04-24: Observational cohort study matching 63 lonafarnib-treated children with progeria to 63 untreated matched patients, finding markedly lower mortality with lonafarnib; the authors caution the design is observational.

Treatment was associated with a lower mortality rate (hazard ratio, 0.12; 95% CI, 0.01-0.93; P = .04). In the combined cohort, there were 4 deaths (6.3%) among 63 patients in the treated group

abstract (vol 319, pp 1687-1695)

Gordon LB et al., 2018-04-24: Observational cohort study matching 63 lonafarnib-treated children with progeria to 63 untreated matched patients, finding markedly lower mortality with lonafarnib; the authors caution the design is observational. Study type: controlled study.